Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma-Bio ServPBSV -27.16%43 Gross Margin % is 33.37% as of Apr. 2026, which is 12% above its 10-year median of 29.72. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 628 Healthcare Providers & Services companies, Pharma-Bio Serv ranks worse than 61.46% on this metric.
The historical rank and industry rank for Pharma-Bio Serv's Gross Margin % or its related term are showing as below:
PBSV'
s Gross Margin % Range Over the Past 10 Years
Min: 25.16 Med: 29.72 Max: 32.35
Current: 32.35
During the past 13 years, the highestGross Margin % of Pharma-Bio Serv was 32.35%. The lowest was 25.16%. And the median was 29.72%.
PBSV's Gross Margin % is ranked worse than 61.46% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs PBSV: 32.35
Pharma-Bio Serv had a gross margin of 33.37% for the quarter that ended in Apr. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Pharma-Bio Serv was 1.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Pharma-Bio Serv had a gross margin of 33.37% for the quarter that ended in Apr. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Pharma-Bio Serv Gross Margin % Related Terms
Pharma-Bio Serv Gross Margin % Historical Data
* Premium members only.
The historical data trend for Pharma-Bio Serv's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PBSV vs MGRX, BFRG, VYND: Gross Margin % Comparison
For the Health Information Services subindustry, Pharma-Bio Serv's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Pharma-Bio Serv (PBSV) has a Gross Margin % of 33.37% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Pharma-Bio Serv and its competitors. This is 12% above median its historical median of 29.72. Over the past decade, Pharma-Bio Serv's Gross Margin % has ranged from 25.16 to 32.35. According to the industry distribution chart, Pharma-Bio Serv ranks #386 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 61.5%.
Is Pharma-Bio Serv's Gross Margin % too high?
Pharma-Bio Serv's current Gross Margin % of 33.37% is 12% above median its 10-year median of 29.72. Over the past 10 years, this metric has ranged from a low of 25.16 to a high of 32.35. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Pharma-Bio Serv's value of 33.37% is 16.7% below this industry median. Based on the distribution chart, Pharma-Bio Serv ranks #386 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's Gross Margin % compare to MGRX and BFRG?
According to the Healthcare Providers & Services industry distribution chart, Pharma-Bio Serv ranks #386 out of 628 companies for Gross Margin %. This places Pharma-Bio Serv in the lower half of its industry. The industry median Gross Margin % is 40.08. Pharma-Bio Serv's value of 33.37% is 16.7% below this benchmark. Historically, Pharma-Bio Serv's own Gross Margin % has ranged from 25.16 to 32.35 over the past decade. While the company's 10-year median is 29.72 vs. the industry median of 40.08, Pharma-Bio Serv has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma-Bio Serv's current Gross Margin % of 33.37% is 16.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Pharma-Bio Serv and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma-Bio Serv's current Gross Margin % is 33.37%, which is 12% above median its own 10-year median of 29.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current Gross Margin % is 33.37%, which is 12% above median its 10-year median of 29.72 and 16.7% below the Healthcare Providers & Services industry median of 40.08. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current Gross Margin % is 33.37% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma-Bio Serv (PBSV) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued.
The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58.
GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.
Key valuation signals for PBSV:
Gross Margin %: 33.37% (12% above median its 10-year median of 29.72)
GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
Industry Position: 16.7% below the Healthcare Providers & Services median (#386 of 628)
No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score
Get the complete analysis for PBSV
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBSV has been successfully added to your 
